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In this study, a new type of silver nanoparticles capped with metronidazolium based ionic liquid is synthesized. By
this aim, metronidazole is altered to ionic-liquid type structure with citrate counter ion as reducing agent. The
produced reducing agent was characterized using 1HNMR and 13CNMR and FT-IR. The capability of
metronidazolium-based reducing agent in formation and capping silver nanoparticles was examined in a chemical
reaction. More speciﬁcally, synthesized silver nanoparticles were synthesized and capped with metronidazoliumcitrate based ionic liquid, while the formation of particles in 48 h was monitored by UV-Vis spectroscopy. Fourier
transform infrared spectroscopy showed the presence of capping agents around silver nanoparticles. The amount
of metronidazolium and citrate as capping agents was determined by thermal gravimetric analysis. The prepared
crystalline structure of silver nanoparticles was proved by X-ray diffraction spectroscopy. PSA analysis and TEM
was performed to determine the size of particles. The synthesized silver nanoparticle has the potential to be used
as an antibacterial agent in preparation of wound dressing with extra capability and efﬁcacy in aerobic and
anaerobic bacterium. In this regard, the antibacterial efﬁcacy of discs from different concentration of silver
nanoparticles in calcium alginate medium were evaluated in Gram-negative and Gram-positive bacterium.

1. Introduction
Nanotechnology is known as an emerging science with great impact
in development of new technologies in the ﬁeld of medicine [1]. Nanomedicine has revolutionized traditional methods of treatment, especially
through the expansion of different types of nanopharmaceuticals, several
of which are currently on the market [2]. Progress in the formation of
nanoparticles (i.e. metallic and non-metallic) have rendered signiﬁcant
innovations in the methods of drug and gene delivery, diagnosis, antimicrobial agents and health care tools [3, 4, 5, 6, 7]. Among metallic
nanoparticles, silver nanoparticles (AgNPs) are of utmost importance and
utility for biomedical applications [8]. AgNPs are mostly known for
antibacterial, antiviral and antifungal activities, but their applications are
not limited to these ﬁelds [9, 10]. Interesting scientiﬁc advancements of
AgNPs' utilization was found in drug delivery, anti-angiogenic and
anti-inﬂammatory activities [11].

Synthesis of AgNPs could be performed through chemical, physical or
biological techniques [12, 13]. Chemical technique is one of the most
efﬁcient and rapid approaches, which is based on the presence of three
components: silver salt, reducing agent and capping or stabilizing agent.
The chemical methods of AgNPs could be regarded as “green” protocol,
while mostly performed in aqueous solution [14]. The presence of
capping agent is mandatory to inhibit naked Ag(0) particles from
agglomeration, control sizes and to provide a platform for further functionalization [15]. Citrate capped AgNPs which are mostly synthesized
through utilization of sodium citrate as reducing agents are proven to
have high stability and be an effective antibacterial agent on
Gram-positive and Gram-negative bacteria [16].
Ionic liquids (IL) have also been applied for synthesis of AgNPs as
stabilizing agents and even as reaction medium. ILs could provide tridimensional hydrophilic networks around nanoparticles and interact
with aqueous medium and ﬁnely support size and shapes [17]. There is
evidence that combining AgNPs and silver complexes with antimicrobial
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instrument (model CM10). To determine the amount of organic coating,
thermal gravimetric analysis (TGA) was performed with Mettler Toledo
instrument.

agents can result in enhancement of antibacterial efﬁcacy. Silver sulfadiazine, a widely applied medication in burn treatment, is one of this
examples [18]. AgNPs capped with antibiotics (i.e. streptomycine,
ampiciline and tetracycline) have rendered increased antibacterial activities in regards of routine types of AgNPs capped with citrate, polyvinylpyrrolidone and sodium dodecylsulfate [19]. Recently, water
soluble complexes of metronidazole-silver had been synthesized, and the
presence of metronidazole proved to enhance the antibacterial efﬁciency
of silver salts in comparison between silver sulfadiazine and free
metronidazole against Gram-positive bacteria [20].
Multidrug resistant (MDR) bacteria stand as one of the challenging
problems in universal health care. Due to antibiotic resistance of pathogens, new formulations are needed to combat. NPs themselves and in
combination with antibiotics offer promising solutions to develop new
and prospective nanomedicines to ﬁght bacteria MDR. AgNPs have
shown to act as an effective agent against MDR bacteria [5]. A synergistic
antibacterial affect was observed while AgNPs were combined with two
antibiotics; gentamicin and chloramphenicol in MDR of Enterococcus
faecalis [21]. In another researches, a combinatorial system of AgNPs and
tetracycline demonstrated to be effective against tetracycline resistant
bacteria [22].
Among biodegradable and natural-based polymers [4], sodium alginate ﬁbers have applications in preparation of wound care dressings [23,
24]. Combination of alginate with AgNPs could result in an enhancement
in healing properties while broadening the antimicrobial spectrum of
wound dresses [25, 26].
Metronidazole is a common type of antibiotic and antiprotozoal that
is prescribed for treatment of a wide range of infections. It is categorized
under the group of nitro-imidazole as an effective treatment of diseases
caused by anaerobic bacteria, such as bacterial vaginosis, endocarditis
and pelvic inﬂammatory diseases [21].
To consider wide arrays of AgNPs applications, and their unique
manifestation as antibacterial agents, development of synthetic techniques that resulted in production of particles with enhanced efﬁciency is
of great interest. Herein, a novel synthetic strategy was expended to
prepare metronidazole-based ionic liquid with citrate counter ion. This
new precursor was applied in synthesis of AgNPs. Finally, to verify the
antibacterial efﬁcacy of as-prepared samples, mixture of AgNPs in calcium alginate was prepared.

4. Experimental section
4.1. Synthesis of metronidazole-based ionic liquid (IL-Met-cit)
To synthesize metronidazole-based ionic liquid, metronidazole (5.8
mmol) was mixed with ethanol (30 ml). Then, methyl iodide (5.8 mmol)
was added, and the reaction ﬂask reﬂuxed at 50  C for one day. A yellow
solution was formed, and the solvent was removed by rotary-evaporator.
After that, the precipitated product was mixed with 20 ml of sodium
chloride (1% W/W) to replace iodide ion with chloride ion. The product
was obtained by evaporation, then re-crystalized in deionized water.
Finally, to insert citrate ion to the structure, the product was admixed
with 100 ml of sodium citrate solution (2% W/W) overnight at 50  C. The
product was obtained by evaporation and re-crystalized in deionized
water (Scheme 1).
1
HNMR and 13CNMR characteristic chemical shifts bands in D2O
solvent;
1
HNMR: δ7.98 (singlet,1H, Ha), δ4.63 (triplet, 2H, He), δ4.45 (triplet,
2H, Hd), δ3.89 (singlet, 3H, Hb), δ2.43 (singlet, 6H, Hh,j,i), δ1.8 (singlet,
3H, Hg).
13
CNMR: δ 181, 179.2 (Cl,Cn, Cm), δ132.7(Cc), δ 108 (Ca, Cc),
δ75.1(Ck), δ60.08 (Cb), δ48 (Ch), 45.6 (Ce, Cd), δ23.203 (Cb), δ 13.3(Cg).
Other characteristics of IL-Met-cit (Scheme 1) containing: melting
point: 152–154  C, white powder without odor and color.
4.2. Synthesis of metronidazole-capped AgNPs (IL-Met-Ag)
To synthesize metronidazole-capped AgNPs, 20 ml of IL-Met-cit (100
mM) was ﬁrst dissolved in DI water and stirred at 50  C. Then 20 ml of
silver nitrate (AgNO3, 10 mM) was added drop-wise over 15 min. The
mixture was stirred and reﬂuxed for 24 h until the creamy mixture obtained. Finally, in order to extract AgNPs, sodium hydroxide solution
(10% W/W) was added drop-wise until precipitation began. The precipitate was extracted from supernatant and washed in deionized water
(x3). The obtained AgNPs (IL-Met-Ag) were dried at room temperature
and stored for further analysis.

2. Materials
4.3. Disc diffusion test

Alginic acid sodium salt (sodium alginate) with MW ¼ 10–600 kDa,
sodium citrate tribasic dehydrate were purchased from Sigma Company.
Silver nitrate (AgNO3) was purchased from Daejung Chemical Company.
Metronidazole was available from Samen Pharmaceutical Company/Iran
(5 mg/ml) and was extracted from injectable solution by recrystallization
and puriﬁcation with deionized water. Calcium chloride, ethanol and
acetone was available from Kimia Mavad (Iran). The standard antibiogram discs of several antibiotics such as imipenem (IPM: 10 μg), amikacin (AN: 30 μg), ceftazidime (CAZ: 30 μg), oxacillin (OXA: 5 μg) and
clindamycin (CC: 10 μg) for S. Aureus, while for Pseudomonas, antibiotics
included gentamicin (GM: 30 μg), azithromycin (AZM: 15 μg), lomeﬂoxacin (LOM: 30 μg), ciproﬂoxacin (CP: 5 μg) and norﬂoxacin (NOR: 5
μg) were prepared from Pars Teb company.

To evaluate antibacterial efﬁciency, an aqueous solution (5 ml) of ILMet-Ag with various concentrations (1, 3, 5, 6, 7, 10, 12, 14, 20, 50, 100,
200, 300 and 400 μg/ml) were prepared in small vials. Then sodium
alginate (0.03 g) was included in the solution, and the mixture was
stirred at room temperature. After 30 min, 0.5 ml of calcium chloride (1%
W/W) was added to the mixture. After 2 h, paper discs were inserted into
each sample and maintained for 24 h. Then, the discs were dried in an
oven at 50  C. The anti-microbial efﬁciency of discs from each samples
was evaluated against Staphylococcus aureus (S. aureus) and Pseudomonas
in comparison to antibiotic discs.
The disc diffusion test by the above mentioned procedures were
repeated for IL-Met-cit and metronidazole with different concentration
(0.15, 0.3, 0.6, 1, 2.5, 5, 10, 15, 20, 50, 100 μg/ml).

3. Instruments
1
HNMR and 13CNMR was performed by Brucker Avance DPX (250
MHz) in D2O solvent. Fourier transform infrared (FTIR) spectra was
operated by Bruker (VERTEX70) instrument, and the spectrums were
recorded by OPUS software. X-ray diffraction (D8 Advance Bruker AXS)
with X-ray diffractometer (Cu Kα radiation with λ ¼ 1.540 A , energy 3
kV, and 15 mA 2θ scan range ¼ 10–90 , 25  C) was applied to record the
crystallinity of synthesized AgNPs. Morphological observation was performed by transmission electron microscope/TEM with a Philips

Scheme 1. IL-Met-cit structure.
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The characterization of products from each steps is determined by FTIR, 1HNMR and 13CNMR support the correct synthetic strategies of ILMet-cit preparation (Figures 2 and 3). AgNPs formation is performed in
aqueous solution and FT-IR spectrum shows successful formation of
metronidazolium- and citrate-capped silver particles (Figure 4). The FTIR
spectrum of IL-Met-Ag is compared with metronidazole. The characteristic peaks of pure metronidazole such as imidazolium ring attributed to
N–C¼N and C¼N group appears at 1530 and 1622 cm1. C–H stretching
vibration is evident at 1180 cm1, the N–O stretching band of NO2 group
appears at 1358 cm1 and C–O stretching vibration is at 1180 cm1.
Regarding IL-Met-Ag spectrum, all attributed peaks of metronidazole
appear with lower intensity and slight chemical shift to higher frequency,
due to the presence of silver. The peak at 1369 cm1 could be attributed
to NO2 group. However, the C¼O group of citrate could appear at 1622
cm1, which has incidence with N–C¼N group.
TGA analysis is performed to determine the amount of organic layer
around IL-Met-Ag particles (Figure 5). The diagram shows weight losses
in two regions. The ﬁrst region begins at 133–176  C, which is related to
water and humidity, while the second is between 348-399  C, indicating
about 2.65% related to weight loss of IL-Met-cit molecules.
X-ray is a powerful technique for determination of crystalline structure at the atomic scale. XRD analysis is performed to identify the crystalline nature and purity of samples [29]. For IL-Met-Ag, the diffraction
peaks appear at 2θ angle of 38.3 , 44.0 , 66.0 and 77.6 , which can be
attributed to the planes of reﬂection in xyz directions of (111), (200),
(220) and (311) of AgNPs that conﬁrm face centered cubic structure of
silver (Figure 6). Two other diffractions recorded in 32.6 and 55.3 directions could be attributed to silver oxide formation [30, 31].
The formation of AgNPs was monitored by UV-Vis spectroscopy
(Figure 7). For this purpose, metronidazole and IL-Met-cit are analyzed to
determine the maximum absorbance wavelength. The maximum absorbance wavelength of metronidazole is between 310-330 nm, similar to a
previous report [32]. The UV-Vis absorbance of IL-Met-cit lies at 310 nm.
During silver nitrate reaction with IL-Met-cit, the recorded UV-Vis
spectrums in the ﬁrst two hours did not show changes indicating absorbance of IL-Met-cit. However, after 24 h, a peak appeared at 410 nm as a
result of AgNPs formation (Figure 7). The sharpness of this peak is
dependent on the concentration of the AgNPs [22].
The particle sizes are measured by PSA. The PSA histogram shows
symmetrical distribution of particle diameter with average size of 60 nm
(Figure 8A). TEM image also conﬁrmed the formation of spherical
particles with the sizes of less than 10 nm. Also, larger particles with
low availability and maximum sizes of 30 nm could be observed
(Figure 8B).

All procedures were performed according to guidelines of Clinical and
Laboratory Standard Institute (CLSI) for primary evaluation of the materials. Brieﬂy, all glassware and medium were sterilized in an autoclave
for 20 min at 121  C. A suspension of Gram-negative and Gram-positive
bacteria Pseudomonas and S. Aureus, respectively was combined with 0.5
McFarland and cultured overnight. The turbidity was adjusted to 108
CFU. To run the tests, the suspension was diluted 105-fold, and 10 μl of
suspension was added to Mueller-Hinton agar plates and dispersed by
swab. The paper discs, with a diameter of 6 mm, contained a certain
concentration of antibiotics, for example, S. Aureus contained antibiotics
IPM, AN, CAZ, OXA and CC, while Pseudomonas contained antibiotics like
GM, AZM, LOM, CP and NOR. On the other hand, the discs prepared in
the previous section were also placed in the plates, which were incubated
at 37  C for 24 h. After this time frame, the zone of inhibition (ZOI) was
measured, and the inhibitory percent was calculated according to the
following formula:
Inhibitory % ¼ ZOI of samples/ZOI of antibiogram discs*100

5. Results
5.1. Synthesis and characterization of IL-Met-cit and IL-Met-Ag
Today, AgNPs have found fascinating applications, especially in the
biomedical ﬁeld, as a masterpiece of nanotechnology progress. In this
regard, it is possible to present innovation from synthetic routes to their
application. Herein, a novel innovation in chemical synthetic routes of
AgNPs is introduced, which leads to preparation of more stable AgNPs
with broader antimicrobial properties.
First, an antibiotic type (metronidazole)-based reducing agent that
also act as stabilizer in the form of ionic liquid is introduced and applied
in preparation of AgNPs (Figure 1). In this method, metronidazole is
reacted chemically with methyl iodide to change the imidazolium ring to
quaternary iodide salt and form IL-Met (Figure 1A) [27, 28]. Then, to
prepare a chemically stable ionic liquid type compound, IL-Met is reacted
with sodium chloride to change the iodide ion, making the molecule
stable for long-term storage at room temperature (Figure 1B). In the next
step, the product is reacted with sodium citrate to prepare IL-Met-cit,
which could have several functions including antibacterial efﬁcacy,
ionic liquid type stabilizing agent and reducing capability (Figure 1C).
The capacity of IL-Met-cit is tested in preparation of AgNPs while reacted
in aqueous medium with silver nitrate for 24 h, which results in the
formation of stabilized AgNPs (IL-Met-Ag) (Figure 1D).

Figure 1. Synthetic processes of AgNPs: ﬁrst preparation of IL-Met-cit, then reaction with silver nitrate.
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Figure 2. 1HNMR spectrum of IL-Met-cit in D2O solvent.

Figure 3.

13

CNMR spectrum of IL-Met-cit in D2O solvent.

Gram-positive bacteria were IPM, AN, CAZ, OX and CC, while for Gramnegative, GM, AZM, LOM, CP and NOR were selected. The percent of
inhibition in regards of types of antibiotics for each samples concentrations are presented in two diagrams for Gram-positive and Gramnegative bacteria (Figure 9). As a comparison, the antibacterial efﬁciency of metronidazole and IL-Met-cit disks in calcium alginate solution
in various concentrations were assessed on Gram-positive and Gramnegative bacteria. However, the disk containing IL-Met-cit and metronidazole couldn't inhibit bacterial growth. Of course, it was previously
well studied that metronidazole is not effective against S. aureus and
P. aeruguinosa in concentration less than 128 mg/L [5].

5.2. Evaluation of antibacterial efﬁciency of IL-Met-Ag nanoparticles
AgNPs have found impactful commercial applications as antimicrobial agents, especially in preparation of wound dresses. By this aim, the
antimicrobial efﬁcacy of IL-Met-Ag nanoparticles is evaluated in calcium
alginate medium as potent wound care dresses. Two different types of
bacteria including Gram S.aureus (as Gram-positive bacteria) and Pseudomonase aeruguinosa (P. aeruguinosa) as (Gram-negative) bacteria are
tested. Antimicrobial discs of different concentrations of IL-Met-Ag are
prepared, then the antibacterial efﬁciency is reported while compared
with antibiotic discs. The antibiotics applied for efﬁcacy evaluation in
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Figure 6. XRD diagram of IL-Met-Ag.

Figure 4. FTIR spectrum of metronidazole and IL-Met-Ag.

wavelenghths. Paramella et al. reported a size and concentration
dependent of extinction coefﬁcient of AgNPs. According to this report
AgNPs with diameter ranging from 10-40 would appear around wavelengths of 390–412 nm [33]. Herein, formation of AgNPs was monitored
at maximum wavelenghth of 410 nm, which was also reported in an other
reference [17]. It is obvious that IL-Met-cit could perform two functions
of reducing and stabilizing of AgNPs efﬁciently. FT-IR of IL-Met-Ag shows
that AgNPs were capped with organic moiety of IL-Met-cit with average
organic layer amount of 2.65%, which is supported by TGA analysis. PSA
analysis demonstrates ﬁne distribution of nanoparticles in aqueous medium with average size of 60 nm, while TEM image shows particles with
sizes around 10 nm. All data prove the successful formation of AgNPs.
The antimicrobial results, which were assessed in calcium alginate
solution of IL-Met-Ag through two types of bacteria including S. aureus as
Gram-positive bacteria and P. aeruguinosa as Gram-negative, showed
high antimicrobial efﬁciency of particles, even in low concentration, in
comparison with antibiotic discs. The highest efﬁcacy of both bacteria
types are observed at 400 μg/ml of IL-Met-Ag. For Gram-positive bacteria, the inhibition efﬁciency is 100% comparable with antibiotics such as
GM, AZM, CP and NOR, while for LOM, nanoaprticles are shown to be
work better with 120% efﬁcacy. For Gram-negative bacteria, the 100%
efﬁcacy is reached at 300 μg/ml for IPM, CAZ, OX, CC, while for AN it
reaches 125% efﬁcacy.
The type of study in this research based on antibacterial inhibitory
percent is very speciﬁc and used for comparison of IL-Met-Ag efﬁcacy for

6. Discussion
Two novel synthetic strategies are developed in this study. The ﬁrst
one results in the transformation of metronidazole to a potent reducing
agent that could stimulate antimicrobial efﬁciency for anaerobic bacteria
and also have ionic liquid type structure. This new introduced low molecular weight compound (IL-Met-cit) that contains citrate ion in the
structure was fully characterized by 1HNMR and 13CNMR and FTIR
spectroscopy (Figures 2, 3, and 4). This compound was produced with
commercially available materials and has the potential to be registered as
a new ionic liquid with metronidazolium-based structure and high
reducing capability. The efﬁciency of this compound could be evaluated
in nanoparticle formation. By this aim, the synthesis of AgNPs was performed with IL-Met-cit compound.
Synthesis of AgNPs has been efﬁciently performed with ionic liquids
by N-alkylethylenediamine [17]. On the other hand, metronidazole
complexes of silver were also synthesized and evaluated for antimicrobial
efﬁcacy [20]. Antibiotic type capping agents are proven to have higher
antibacterial efﬁciency rather than AgNPs [19]. In this regard, the synthesis of AgNPs is performed in aqueous medium in the presence of
IL-Met-cit, which results in the formation of AgNPs after 24 h. Due to
plasmonic properties of AgNPs, Uv-Vis spectroscopy could be recognized
as valid method of in situ monitoring of synthetic processes. The size and
shapes of AgNPs are determining factor in their absorbance

Figure 5. TGA diagram of IL-Met-Ag.
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Figure 7. UV-Vis spectrum of metronidazole, IL-Met-cit and the reaction medium of synthetic process of AgNO3 with IL-Met-cit during ﬁrst two hours: IL-Met-Ag (1 h),
IL-Met-Ag (1.5 h) and IL-Met-Ag (2 h), and IL-Met-Ag (24 h).

Figure 8. (A) PSA diagram of IL-Met-Ag dispersed in DI, (B) TEM image of IL-Met-Ag.

resulted in bacteria inactivation [34]. Other possible mechanisms are
described to be reactive oxygen species (ROS) production by AgNPs and
silver ions and direct damage of cell membrane by AgNPs [35]. A
detailed mechanistic studies are needed to discuss about possible antibacterial mechanism of our synthesized particles. However, we can
propose that IL-Met-Ag with positive charge have potential to penetrate
cells and within cytoplasm metronidazole could react with DNA and
disrupt cell replication while AgNPs would generate ROS and cause cell
death.
The biological safety of metal-oxide nomaterials are highly dependent
on the physicochemical properties such as shape and dimensions, surface
modiﬁcations and surface charge. AgNPs toxicity may depend on the
surface coating since having positive surface charge renders them more
biocompatible, especially for drug delivery purposes [5].
Synthesized AgNPs could be recognized as potent antimicrobial agent
in the preparation of wound care dresses and could provide broad
spectrum of antibacterial efﬁciency in comparison with citrate-capped
AgNPs. However, the prepared nanoparticles also have potential

broad range of antibiotics. The conjugation of metronidazole to AgNPs
means that the system has potential to be considered as nano-drug delivery system and can be applied to combat MDR resistance. For example,
synergistic antibacterial effect of AgNPs in combination with gentamicin
and neomycin antibiotics was investigated on S. aureus bacteria. The
results of disc diffusion test showed that AgNPs/gentamicine reduced the
resistance to gentamicin to 15% and in AgNPs/neomycin the resistance
to neomycin was reduced to 45%. In another study, synergistic effect of
AgNPs with gentamicin and chloramphenicol was proved by measuring
zone of inhibition via standard disc diffusion method against Enterococcus
faecalis [21]. By determining the minimum inhibitory concentration
(MIC) of a combinatorial system of AgNPs and tetracycline better antibacterial activity were obtained against S. aureus and E.coli rather than
AgNPs alone [22].
The antimicrobial mechanism of AgNPs is still not well understood
[34]. However, most of the reports have emphasized the production of
silver ions (Agþ) as determining factor in antimicrobial effect. Silver ions
can react with the thiol groups of bacteria membrane protein which
6
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Figure 9. Antibacterial efﬁcacy of calcium alginate containing IL-Met-Ag solution with different concentrations (3, 6, 12, 20, 50, 100, 200, 300 and 400 μg/ml) for: A)
P. aeruguinosa bacteria in regards to GM, AZM, LOM, CP and NOR antibiotics and B) S. aureus bacteria in regard to IPM, AN, CAZ, OX and CC antibiotics.

results, in combination with FTIR observation of IL-Met-cit, have veriﬁed that IL-Met-cit could successfully play two roles of being both
reducing and stabilizing agents. The XRD shows the expected crystallinity of AgNPs and PSA results, while TEM images show AgNPs formation with sizes less than 50 nm. The antimicrobial results, which are
assessed in calcium alginate solution of IL-Met-Ag, through two types of
bacteria including Gram-positive bacteria Gram-negative demonstrated
high antimicrobial efﬁciency of particles, even in low concentration of
AgNPs, in comparison with commercial antibiotic discs. Our results
suggest that IL-Met-Ag could be considered as novel antibacterial
agents.

efﬁciency for killing anaerobic bacteria that could not be tested in this
work. The variety of different antibiotics applied for comparing efﬁcacy
of prepared IL-Met-Ag particles is of great strength in this work.
7. Conclusion
A successful strategy, leading to novel antibiotic like ionic liquid
with reduction capability, was introduced. Metronidazolium-based
ionic liquid with citrate counter ion are synthesized and characterized. Uv-Vis monitoring shows successful formation of AgNPs after 24 h.
TGA diagrams prove that AgNPs have 2.65% organic layer coating. TGA
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